SOURCE: PharmStar Pharmaceuticals, Inc.

April 08, 2011 08:49 ET

PharmStar Pharmaceuticals, Inc. Effects Corporate Name Change and Begins Trading Under New Symbol "PHAR" at the Open of Market Today

ROCKY MOUNT, NC--(Marketwire - Apr 8, 2011) - PharmStar Pharmaceuticals, Inc., [formerly (PINKSHEETS: BMGI)], (PINKSHEETS: PHAR), a U.S. drug developer, manufacturer and marketer of the FDA-approved, Over-the-Counter (OTC) liquid pain reliever Aquaprin™, announced today that FINRA has approved its corporate name change from Big Star Media Group, Inc. to PharmStar Pharmaceuticals, Inc. In addition, effective at the open of market today, PharmStar Pharmaceuticals, Inc. will begin trading under its newly assigned FINRA symbol "PHAR" on the OTC Pink Sheets.

The Company also announced today that its Capitalization Restructuring has been finalized as follows: the par value of its common shares was changed to $.025, and its total issued and authorized shares are equal to 999,184,352, of which restricted shares total 907,688,847 and free trading shares total 91,495,505. The Company's financial filings are available at Once the latest filings are approved by OTC Markets, the Company will achieve "Current Information" status on the OTC Markets exchange.

About PharmStar Pharmaceuticals
PharmStar Pharmaceuticals, Inc. is a U.S.-based drug development, manufacturing and marketing company and the innovator of Aquaprin™, an FDA-approved Over-the-Counter (OTC) liquid pain reliever. In development since 1993 with over $3 million invested to-date, Aquaprin™ is a liquid derivative of aspirin based on a patent-pending formula. The product is designed to dissolve nearly instantly in just 1.5 ounces of water, which can be absorbed into the bloodstream up to 10 times faster than traditional OTC pain relievers, and with little to no stomach upset. PharmStar's headquarters are located in Rocky Mount, NC. For more information, visit

Forward-Looking Statements Disclosure
This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "will," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Contact Information